[Bori Pharmaceuticals: Termination of issuance of H shares and listing on the main board of the Hong Kong Stock Exchange] On September 30, Borui Pharmaceuticals (688166.SH) announced that the company has decided to terminate the previously planned issuance of H shares and listing on the main board of the Hong Kong Stock Exchange and will no longer apply for an extension. The company held a board of directors meeting on September 30, 2026 to review and approve relevant proposals. This termination matter does not need to be submitted to the shareholders' meeting for review. The company stated that the termination was a prudent decision based on a comprehensive weighing of multiple factors and the actual situation, and would not have a significant adverse impact on production, operations and sustainable development.